One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Xeno series and SF003 serum-free medium for MDCK cells
Category:Laboratory > Laboratory Consumable > Medium Product Name:Xeno series and SF003 serum-free medium for MDCK cells CAS No.:N/A Price(USD):Negotiable Company:Shanghai BioEngine Sci-Tech Co., Ltd.
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Independently developed serum-free media especially for the production of human flu virus and influenza vaccine with MDCK cells
The BioEngine R&D team started the research in techniques for the culture of MDCK cells in 1995. Based on more than 10 years of technology accumulation and an AI-intelligent high-throughput data screening platform, BioEngine has released the Xeno series and SF003 MDCK serum-free media for MDCK cells.
Xeno series media are applicable for the rapid adaptation of MDCK cells, support high-density culture, and the high-efficiency proliferation of various flu virus subtypes. The series media have been applied in the CTA of human flu vaccines.
SF003 is suitable for the rapid adaptation of MDCK cells, supporting high-density culture, as well as the high-efficiency proliferation of avian influenza and swine influenza viruses, and has been applied in several industrial production projects.
Features
Serum free
Animal-derived component-free
Protein free
Support rapid serum-free suspension adaptation of adherent MDCK cells
Support high-efficiency proliferation and high-density culture of MDCK cells
Xeno supports high-efficiency proliferation of the human flu virus
SF003 supports high-efficiency proliferation of avian influenza and swine influenza viruses
Advantages
Xeno series MDCK Serum-Free Media
ADCF; TSE/BSE statement available on demand;
Distinctive culture results proven in numerous studies on human flu virus subtypes;
Optional powder media for use in large-scale manufacturing with easy preparation procedures;
Powder media capable of a single batch size of 100,000 L;
Excellent inter-batch consistency (CPK* > 1.33);
Full traceability by EU-certified ISO13485:2016 Quality Management System;
Complete documents in support of CTA for easier regulatory submission.
SF003 MDCK Serum-Free Media
Distinctive culture results proven in numerous studies on avian influenza virus subtypes;
Optional powder media for use in large-scale manufacturing with easy preparation procedures;
Powder media capable of a single batch size of 100,000 L;
Excellent inter-batch consistency (CPK* > 1.33);
Full traceability by EU-certified ISO13485:2016 Quality Management System.
*CPK is a standard index to state the capability of one process. CPK>1.33: the process is capable and meets specification limits. The higher the CPK, the better.
Audited Supplier
Pharma Sources Insight January 2025
